CurrentEndo coverage · page 20 of 33

Cardiovascular Diabetology

Briefs 761–800 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol7 Aug 2024
Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol7 Aug 2024
Predicting gestational diabetes mellitus risk at 11–13 weeks’ gestation: the role of extrachromosomal circular DNA
Diagnostic or prognostic studyDiabetes in pregnancy
Cardiovasc Diabetol7 Aug 2024
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Cohort studyT2D & other
Cardiovasc Diabetol5 Aug 2024
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial
Secondary analysisT2D & other
Cardiovasc Diabetol3 Aug 2024
N-terminal pro-B-type natriuretic peptide levels vary by ethnicity and are associated with insulin sensitivity after gestational diabetes mellitus
Cross-sectional studyDiabetes in pregnancy
Cardiovasc Diabetol3 Aug 2024
Epicardial adipose tissue volume and density are associated with heart failure with improved ejection fraction
Cohort study
Cardiovasc Diabetol2 Aug 2024
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy
Secondary analysisComplications
Cardiovasc Diabetol2 Aug 2024
Association of triglyceride-glucose index with the risk of incident aortic dissection and aneurysm: a large-scale prospective cohort study in UK Biobank
Cohort study
Cardiovasc Diabetol1 Aug 2024
Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
Cohort studyT2D & other
Cardiovasc Diabetol29 Jul 2024
Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study
Case-control studyT2D & other
Cardiovasc Diabetol29 Jul 2024
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Cohort studyT2D & other
Cardiovasc Diabetol27 Jul 2024
Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population‑based cohort study
Cohort studyT2D & other
Cardiovasc Diabetol25 Jul 2024
Associations of phosphorus concentrations with medial arterial calcification in lower-extremity arteries and diabetic foot in people with diabetes: a retrospective cross-sectional study
Cross-sectional studyComplications
Cardiovasc Diabetol24 Jul 2024
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol23 Jul 2024
Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors
Cohort study
Cardiovasc Diabetol22 Jul 2024
Endothelial microRNAs in INOCA patients with diabetes mellitus
Cohort studyComplications
Cardiovasc Diabetol22 Jul 2024
Sex differences in clinical profile, left ventricular remodeling and cardiovascular outcomes among diabetic patients with heart failure and reduced ejection fraction: a cardiac-MRI-based study
Cohort studyComplications
Cardiovasc Diabetol22 Jul 2024
Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography
Cohort studyT2D & other
Cardiovasc Diabetol18 Jul 2024
Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
Cohort studyT2D & other
Cardiovasc Diabetol18 Jul 2024
A high-volume study on the impact of diabetes mellitus on clinical outcomes after surgical and percutaneous cardiac interventions
Cohort studyT2D & other
Cardiovasc Diabetol18 Jul 2024
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999–2018
Cross-sectional studyLipids & liver
Cardiovasc Diabetol18 Jul 2024
Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol18 Jul 2024
The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol18 Jul 2024
Association of diabetes with cardiovascular calcification and all-cause mortality in end-stage renal disease in the early stages of hemodialysis: a retrospective cohort study
Cohort studyComplications
Cardiovasc Diabetol18 Jul 2024
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry
Cohort studyT2D & other
Cardiovasc Diabetol16 Jul 2024
Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery
Mechanistic study
Cardiovasc Diabetol16 Jul 2024
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
Cohort studyT2D & other
Cardiovasc Diabetol16 Jul 2024
Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005–2018
Cohort studyLipids & liver
Cardiovasc Diabetol16 Jul 2024
BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study
Secondary analysisT2D & other
Cardiovasc Diabetol13 Jul 2024
Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort
Cross-sectional studyT2D & other
Cardiovasc Diabetol13 Jul 2024
DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Case-control studyT2D & other
Cardiovasc Diabetol11 Jul 2024
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial
Secondary analysisT2D & other
Cardiovasc Diabetol11 Jul 2024
Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol10 Jul 2024
Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol10 Jul 2024
Longitudinal economic burden of incident complications among metabolic syndrome populations
Cohort studyLipids & liver
Cardiovasc Diabetol10 Jul 2024
Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018
Cohort studyLipids & liver
Cardiovasc Diabetol10 Jul 2024
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial
Randomized controlled trialLipids & liver
Cardiovasc Diabetol8 Jul 2024
Genome-scale metabolic network of human carotid plaque reveals the pivotal role of glutamine/glutamate metabolism in macrophage modulating plaque inflammation and vulnerability
Mechanistic study
Cardiovasc Diabetol8 Jul 2024
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial
Trial designT2D & other
Cardiovasc Diabetol8 Jul 2024
Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signaling
Mechanistic studyT2D & other

All 1,291 Briefs in ExploreShowing Briefs 761–800 of 1,291, newest first